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Abstract 
Background: Prone positioning is recommended for patients with moderate‑to‑severe acute respiratory distress syn‑
drome (ARDS) receiving mechanical ventilation. While the debate continues as to whether COVID‑19 ARDS is clinically 
different from non‑COVID ARDS, there is little data on whether the physiological effects of prone positioning differ 
between the two conditions. We aimed to compare the physiological effect of prone positioning between patients 
with COVID‑19 ARDS and those with non‑COVID ARDS.
Methods: We retrospectively compared 23 patients with COVID‑19 ARDS and 145 patients with non‑COVID ARDS 
treated using prone positioning while on mechanical ventilation. Changes in  PaO2/FiO2 ratio and static respiratory 
system compliance (Crs) after the first session of prone positioning were compared between the two groups: first, 
using all patients with non‑COVID ARDS, and second, using subgroups of patients with non‑COVID ARDS matched 1:1 
with patients with COVID‑19 ARDS for baseline  PaO2/FiO2 ratio and static Crs. We also evaluated whether the response 
to the first prone positioning session was associated with the clinical outcome.
Results: When compared with the entire group of patients with non‑COVID ARDS, patients with COVID‑19 ARDS 
showed more pronounced improvement in  PaO2/FiO2 ratio [adjusted difference 39.3 (95% CI 5.2–73.5) mmHg] and 
static Crs [adjusted difference 3.4 (95% CI 1.1–5.6) mL/cmH2O]. However, these between‑group differences were not 
significant when the matched samples (either  PaO2/FiO2‑matched or compliance‑matched) were analyzed. Patients 
who successfully discontinued mechanical ventilation showed more remarkable improvement in  PaO2/FiO2 ratio 
[median 112 (IQR 85–144) vs. 35 (IQR 6–52) mmHg, P = 0.003] and static compliance [median 5.7 (IQR 3.3–7.7) vs. 
− 1.0 (IQR − 3.7–3.0) mL/cmH2O, P = 0.006] after prone positioning compared with patients who did not. The asso‑
ciation between oxygenation and Crs responses to prone positioning and clinical outcome was also evident in the 
adjusted competing risk regression.
Conclusions: In patients with COVID‑19 ARDS, prone positioning was as effective in improving respiratory physiol‑
ogy as in patients with non‑COVID ARDS. Thus, it should be actively considered as a therapeutic option. The physi‑
ological response to the first session of prone positioning was predictive of the clinical outcome of patients with 
COVID‑19 ARDS.
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Background
After its first outbreak in Wuhan, China in December 
2019, coronavirus disease 2019 (COVID-19) spread rap-
idly around the world and continues to be a global threat 
[1]. Although most patients with COVID-19 have mild 
manifestations, the condition deteriorates in approxi-
mately 10–20% of patients, requiring admission to an 
intensive care unit and invasive mechanical ventilation 
for acute respiratory distress syndrome (ARDS) [2–4]. 
Whether ARDS due to COVID-19 (COVID-19 ARDS) is 
clinically distinct from ARDS due to other causes (non-
COVID ARDS) has been a controversial issue [5, 6].
Prone positioning is currently implemented for 
patients with moderate-to-severe ARDS with the poten-
tial to reduce mortality [7]. The beneficial effect of prone 
positioning on oxygenation has been known for decades, 
but whether the improvement in oxygenation is directly 
associated with patients’ survival gain has been ques-
tionable [8]. We have recently shown that the extent of 
improvement in the ratio of partial pressure of arterial 
oxygen  (PaO2) to the fraction of inspired oxygen  (FiO2) 
after prone positioning could be a predictor of survival of 
patients with ARDS [9].
In this study, we aimed to investigate whether physi-
ological responses to prone positioning differ between 
patients with COVID-19 ARDS and those with non-
COVID ARDS, focusing not only on oxygenation, but 
also on static respiratory system compliance (Crs), con-
sidering recent studies that reported a prognostic value 
of static Crs for COVID-19 ARDS [10, 11]. We also 
evaluated whether the response to the first session of 




This study was a retrospective cohort study using the 
patients’ medical records conducted at the Seoul National 
University Hospital, a tertiary referral hospital in South 
Korea, which has served as a nationally designated hos-
pital for patients with severe and critical COVID-19. This 
study was approved by the institutional review board of 
the Seoul National University Hospital (IRB No. 2012-
036-1179). We reviewed the records of all patients older 
than 18 years who were admitted to our center between 
January and December 2020 after being diagnosed as 
having COVID-19 using reverse transcription-polymer-
ase chain reaction assay. Among such patients, those for 
whom mechanical ventilation was initiated and prone 
positioning was implemented were included in this study.
Treatment and prone positioning
Patients with COVID-19 ARDS were treated based on 
the most updated evidence at the time of their hospitali-
zation [12, 13]. In patients with worsening respiratory 
failure, we usually used a high flow nasal cannula at first, 
but mechanical ventilation with endotracheal intubation 
was initiated in refractory cases [14]. If  PaO2/FiO2 ratio 
after initiation of mechanical ventilation was less than 
200  mmHg, we actively considered prone positioning 
with neuromuscular blockade [7, 15]. Prone position was 
maintained for at least 16 h per day [7]. Discontinuation 
of prone positioning was considered if reduction in venti-
lator assistance was possible allowing for spontaneous or 
assisted ventilation.
Comparison with non‑COVID ARDS
We reviewed every patient with non-COVID ARDS 
treated using prone positioning while on mechanical 
ventilation since January 2014 until December 2020, and 
the cohort of these patients was used for a comparison 
between COVID-19 ARDS and non-COVID ARDS. 
Some of these patients were included in our previous 
study [9]. First, we used the entire group of patients with 
non-COVID ARDS while adjusting for the between-
group differences. Second, for a more accurate compari-
son, patients with COVID-19 ARDS were matched with 
subgroup populations among the non-COVID ARDS 
group: one matched 1:1 for  PaO2/FiO2 ratio and one 
matched 1:1 for static Crs.
Study outcome and data collection
The primary outcome of this study was the extent of 
changes in  PaO2/FiO2 ratio and static Crs after the first 
prone positioning session. In each patient, the changes 
in  PaO2/FiO2 ratio and static Crs were tracked during 
the first prone positioning session. Using the results of 
arterial blood gas analysis and the ventilator setting at 
the time of blood sampling,  PaO2/FiO2 ratio and static 
Crs were evaluated at four timepoints for each patient: 
baseline (before initiation of prone positioning), P1 
(approximately 10 h after initiation of prone positioning), 
P2 (approximately 16 h after initiation of prone position-
ing, which is the last timepoint before cessation of prone 
positioning), and S1 (approximately 2 h after changing to 
supine position). For the main outcome of this study, each 
Keywords: COVID‑19, Acute respiratory distress syndrome, Prone position, Oxygenation, Respiratory system 
compliance
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patient’s response to the first session of prone positioning 
was calculated as the difference in  PaO2/FiO2 ratio and 
static Crs between the baseline and P2 timepoints. In 
addition, we aimed to evaluate whether the physiological 
responses to prone positioning correlate with the clinical 
outcomes of patients, given the controversial results of 
previous studies [9, 16].
Statistical analysis
We assessed the differences between patients with 
COVID-19 ARDS and those with non-COVID ARDS and 
P values of < 0.05 for two-tailed tests were considered sta-
tistically significant. First, all patients with non-COVID 
ARDS were compared with patients with COVID-19 
ARDS. Then, two subgroup populations of patients with 
non-COVID ARDS were used for 1:1 matched compari-
son with patients with COVID-19 ARDS  (PaO2/FiO2-
matched subgroup and compliance-matched subgroup). 
The matching was performed using an optimal algorithm 
without replacement [17].
For each patient, the Wilcoxon singed-rank test 
was used to compare the  PaO2/FiO2 ratio and static 
Crs between different timepoints Then, the extent of 
changes in these parameters from baseline to P2 time-
points was compared between the COVID-19 ARDS and 
non-COVID ARDS groups using multivariable linear 
regression analysis. Comparisons between the matched 
samples were performed similarly [18]. Because there are 
no definite well-known predictors for response to prone 
positioning, we adjusted for age, sex, body mass index, 
duration of mechanical ventilation before the initiation 
of prone positioning, sequential organ failure assessment 
(SOFA) score, Charlson comorbidity index (CCI), and 
baseline setting of mechanical ventilator (positive end-
expiratory pressure [PEEP] and tidal volume) as well as 
baseline  PaO2/FiO2 ratio, static Crs, and ventilatory ratio. 
Ventilatory ratio was selected as a parameter to assess the 
efficacy of ventilation because we did not routinely moni-
tor the expired  CO2 level [19].
For patients with COVID-19 ARDS treated using prone 
positioning, we assessed whether the response of  PaO2/
FiO2 and static Crs could predict patients’ probability 
of successful discontinuation of mechanical ventilation 
within 90  days using a receiver operating characteristic 
(ROC) analysis. In addition, the Fine and Gray compet-
ing risk regression analysis was performed to calculate 
the subdistribution hazard ratio (SHR) and 95% confi-
dence interval (CI) with adjustment for age, sex, SOFA 
score, CCI, and baseline  PaO2/FiO2 ratio and static Crs 
[20, 21]. Death occurring during mechanical ventilation 
was considered as the competing event. Patients who 
were still dependent on mechanical ventilation were cen-
sored at 90 days after the first prone positioning session. 
All statistical analyses were performed using STATA soft-




Until December 2020, 46 patients with COVID-19 ARDS 
were treated at our center using mechanical ventila-
tion. Among them, 23 patients (50%) did not start prone 
positioning because their oxygenation status rapidly 
improved after initiation of mechanical ventilation. The 
remaining 23 patients (50%) were treated using prone 
positioning for persistent moderate-to-severe ARDS. 
The median interval between the diagnosis of COVID-
19 and initiation of prone positioning was 9 (interquar-
tile range [IQR] 4–12) days. To compare with patients 
with COVID-19 ARDS, 145 patients with non-COVID 
ARDS treated using prone positioning were reviewed and 
among them, two subgroups of 23 patients (1:1 matched 
for  PaO2/FiO2 ratio and static Crs, respectively) were 
selected.
Comparison of baseline characteristics and respira-
tory mechanics between these groups are described in 
Tables  1, 2. The patients with non-COVID ARDS had 
more comorbidities and they were more severely ill 
with more organ dysfunctions and higher SOFA scores 
than the patients with COVID-19 ARDS. They also 
showed worse oxygenation (median  PaO2/FiO2 ratio 96 
vs. 107  mmHg, P = 0.037) and lower static Crs (median 
21.9 vs. 27.2 mL/cmH2O, P = 0.005). All patients in both 
groups received ventilation with low tidal volume, but 
patients with non-COVID ARDS had higher ventila-
tory ratio (median 2.2 vs. 1.7, P < 0.001), requiring higher 
minute ventilation (median 177 vs. 140  mL/kg/min, 
P < 0.001). Among the patients with non-COVID ARDS, 
1:1 matching was well performed, showing no between-
group differences in the median values of  PaO2/FiO2 ratio 
and static Crs in  PaO2/FiO2-matched and compliance-
matched samples, respectively.
Oxygenation and static compliance responses
The changes in  PaO2/FiO2 ratio and static Crs after the 
first session of prone positioning are described in Fig. 1 
and Additional file  1: Table  S1. Baseline measurements 
were performed at a median of 1.3 (IQR 0.7–2.8) hours 
before initiation of prone positioning. Measurements for 
P1 and P2 timepoints were performed at a median of 9.7 
(IQR 7.6–11.2) hours and 16.0 (IQR 13.5–17.8) hours 
after initiation of prone positioning, respectively. Most 
patients with COVID-19 ARDS showed improvement 
in both  PaO2/FiO2 ratio and static Crs after prone posi-
tioning. The increase in  PaO2/FiO2 ratio was the most 
prominent at the P1 timepoint and it slightly decreased 
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when patients were moved to a supine position (Fig. 1A 
and Additional file 1: Table S1). The static Crs showed a 
continuous gradual increase during the first prone posi-
tioning session (Fig. 1B and Additional file 1: Table S1). 
A detailed comparison between patients with COVID-19 
ARDS and those with non-COVID ARDS is presented in 
Table 3.
When comparing baseline and P2 timepoints, the 
absolute improvement in  PaO2/FiO2 ratio was higher 
in patients with COVID-19 ARDS [median 89.8 (IQR 
35.3–135.2) mmHg] than in patients with non-COVID 
ARDS [median 40.1 (IQR 7.0–77.5) mmHg]. The dif-
ference between the two groups remained significant 
after adjusting for other variables when the analysis 
was conducted using the entire group of patients with 
non-COVID ARDS [adjusted difference 39.3 (95% CI 
5.2–73.5) mmHg]. However, when compared with the 
matched subgroups of patients with non-COVID ARDS, 
it was not significant [adjusted difference 4.0 (95% CI 
−  62.9–71.0) mmHg in  PaO2/FiO2-matched samples 
and 58.4 (95% CI −  13.5–130.2) mmHg in compliance-
matched samples].
The absolute change in static Crs between baseline 
and P2 timepoints was also higher in patients with 
COVID-19 ARDS [median 3.7 (IQR −  1.0–7.3) mL/
cmH2O] than in patients with non-COVID ARDS 
[median − 0.3 (IQR − 4.0–1.9) mL/cmH2O]. However, 
similar to the case of  PaO2/FiO2 ratio, after adjusting 
for other variables, this difference in static Crs was sig-
nificant only when the analysis was conducted using 
the entire group of patients with non-COVID ARDS 
[adjusted difference 3.4 (95% CI 1.1–5.6) mL/cmH2O]. 
The significance was lost in the analysis of matched 
samples [adjusted difference 0.3 (95% CI −  3.3–3.8) 
mL/cmH2O in  PaO2/FiO2-matched samples and 2.2 
(95% CI − 2.4–6.7) mL/cmH2O in compliance-matched 
samples].
As a sensitivity analysis, we compared the relative 
percentage changes in  PaO2/FiO2 ratio and static Crs 
between the two groups (COVID-19 ARDS and non-
COVID ARDS). The relative percentage change was cal-
culated as the absolute change divided by the baseline 
reference value. The results of this sensitivity analysis 
were similar to those of the main analysis (Additional 
file 1: Table S2). The unmatched analysis suggested that 
the relative percentage improvement in  PaO2/FiO2 ratio 
and static Crs was more prominent in patients with 
COVID-19 ARDS than in patients with non-COVID 
ARDS. However, the significance was lost in the analysis 
of matched samples.
Table 1 Patient characteristics
APACHE acute physiology and chronic health evaluation, ARDS acute respiratory distress syndrome, SAPS Simplified Acute Physiology Score, SOFA sequential organ 
failure assessment
a P values are for comparison between patients with COVID-19 ARDS and patients with non-COVID ARDS
Variables COVID‑19 ARDS Non‑COVID ARDS
Entire group N = 23 Entire group N = 145 P  valuea PaO2/FiO2‑matched 
N = 23




Age, years 70 (63–74) 67 (59–74) 0.222 75 (70–79) 0.092 66 (60–74) 0.159
Male sex 15 (65.2%) 97 (66.9%) 0.874 17 (73.9%) 0.522 16 (69.6%) 0.753
Height, cm 165 ± 9 163 ± 8 0.374 163 ± 10 0.614 164 ± 8 0.791
Body weight, kg 70 (58–79) 61 (53–70) 0.018 57 (51–69) 0.015 64 (55–69) 0.132
Body mass index, kg/m2 25.6 (22.9–27.4) 22.9 (20.8–26.0) 0.024 22.5 (19.3–24.7) 0.009 22.7 (20.5–27.2) 0.121
Interval between intuba‑
tion and the first prone 
positioning session, 
days
1 (0–2) 2 (1–5) 0.009 1 (0–3) 0.116 2 (1–4) 0.047
Total number of sessions 
of prone positioning
4 (3–9) 2 (1–4) < 0.001 2 (1–4) 0.008 2 (1–4) 0.011
Mean duration of prone 
positioning per session, 
hours
18 (17–19) 18 (16–19) 0.653 17 (16–18) 0.180 17 (16–20) 0.231
Charlson comorbidity 
index
4 (3–4) 5 (3–8) 0.012 5 (4–6) 0.011 5 (4–7) 0.032
APACHE II score 20 (12–25) 29 (25–33) < 0.001 30 (26–35) < 0.001 29 (25–37) < 0.001
SAPS II score 42 (31–61) 65 (55–71) < 0.001 66 (62–78) < 0.001 65 (58–78) < 0.001
SOFA score 8 (5–11) 12 (9–14) < 0.001 12 (9–14) 0.002 13 (11–15) < 0.001
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Table 2 Baseline respiratory mechanics and clinical outcomes
ARDS acute respiratory distress syndrome, Ct value cycle threshold value, ECCO2R extracorporeal carbon dioxide removal, ECMO extracorporeal membrane 
oxygenation, FiO2 fraction of inspired oxygen, PaCO2 partial pressure of carbon dioxide, PaO2 partial pressure of oxygen, PBW predicted body weight, PEEP positive 
end expiratory pressure, RT-PCR reverse transcription polymerase chain reaction
a P values are for comparison between patients with COVID-19 ARDS and patients with non-COVID ARDS
Variables COVID‑19 ARDS Non‑COVID ARDS
Entire group N = 23 Entire group N = 145 P  valuea PaO2/FiO2‑matched 
N = 23
P  valuea Compliance‑matched 
N = 23
P  valuea
Arterial blood gas analysis
 pH 7.37 (7.34–7.39) 7.34 (7.28–7.40) 0.173 7.36 (7.26–7.40) 0.291 7.34 (7.28–7.41) 0.568
  PaCO2, mmHg 44 (40–49) 49 (40–55) 0.139 48 (45–54) 0.071 46 (37–54) 0.860
  PaO2, mmHg 75 (66–80) 71 (62–85) 0.467 79 (65–93) 0.391 69 (55–78) 0.097
  HCO3, mEq/L 24.9 (24.1–28.4) 24.2 (21.5–27.3) 0.161 23.3 (21–28.6) 0.191 23.3 (18.6–28.6) 0.240
Ventilator  FiO2 0.7 (0.6–0.8) 0.8 (0.65–1.0) 0.047 0.75 (0.6–0.9) 0.537 0.75 (0.7–1.0) 0.221
PaO2/FiO2 ratio, mmHg 107 (92–132) 96 (74–120) 0.037 107 (92–131) 1.000 90 (72–104) 0.007
PEEP,  cmH2O 12 (9–13) 10 (8–11) 0.016 10 (7–10) 0.063 10 (8–11) 0.135
Driving pressure, 
 cmH2O
13 (12–16) 18 (15–21) < 0.001 18 (15–22) 0.001 15 (13–18) 0.096
Respiratory rate, 
breaths/min
21 (19–27) 27 (24–30) 0.002 26 (25–30) 0.012 24 (21–30) 0.116
Tidal volume per PBW, 
mL/kg
6.3 (5.6–7.0) 6.6 (6.0–7.3) 0.126 6.4 (5.9–7.2) 0.734 6.5 (5.9–9.0) 0.177
Minute ventilation per 
PBW, mL/kg/min




27.2 (21.9–32.7) 21.9 (18.2–26.5) 0.005 20.0 (15.6–27.2) 0.008 27.2 (21.9–32.7) 0.983
Ventilatory ratio 1.7 (1.4–2.0) 2.2 (1.7–2.7)  < 0.001 2.1 (1.7–2.5) 0.015 2.2 (1.7–2.6) 0.002
Laboratory results
 White blood cell, 
 103/μL
10.46 (6.53–16.04) 13.36 (5.73–17.77) 0.717 15.73 (13.14–23.71) 0.008 10.01 (5.73–16.86) 0.904
 Segmented neutro‑
phil,  103/μL
9.66 (5.88–14.57) 11.42 (4.93–15.06) 0.906 14.40 (11.53–19.56) 0.014 9.56 (4.53–14.43) 0.684
 Lymphocyte,  103/μL 0.69 (0.48–0.86) 0.43 (0.18–0.84) 0.047 0.70 (0.27–0.98) 0.895 0.51 (0.16–0.88) 0.249
 C‑reactive protein, 
mg/dL
10.9 (6.3–19.8) 13.5 (6.6–21.5) 0.234 13.8 (7.6–21.5) 0.449 19.2 (9.1–25.7) 0.037
 RT‑PCR for SARS‑CoV‑2
  Ct value for env 
gene
23.01 ± 4.99




 Inhaled nitric oxide 8 (34.8%) 56 (38.6%) 0.725 4 (17.4%) 0.179 8 (34.8%) 1.000
 Renal replacement 
therapy
4 (17.4%) 29 (20.0%) 1.000 2 (8.7%) 0.665 7 (30.4%) 0.491
 ECMO or  ECCO2R 3 (13.0%) 7 (4.8%) 0.141 0 (0.0%) 0.233 2 (8.7%) 1.000
 Tracheostomy 12 (52.2%) 59 (40.7%) 0.300 15 (65.2%) 0.369 6 (26.1%) 0.070
90‑days clinical outcome
 Successful discontinu‑
ation of mechanical 
ventilation
16 (69.6%) 27 (18.6%) < 0.001 5 (21.7%) 0.005 4 (17.4%) 0.001
 Dependent on 
mechanical ventila‑
tion
2 (8.7%) 11 (7.6%) 5 (21.7%) 1 (4.3%)
 Death 5 (21.7%) 107 (73.8%) 13 (56.6%) 18 (78.3%)
 Ventilator free days 45 (0–82) 0 (0–0) < 0.001 0 (0–0) 0.002 0 (0–0) 0.002
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Given that the respiratory distress in patients with 
non-COVID ARDS had various underlying causes, we 
performed a subgroup analysis according to the etiol-
ogy of ARDS in patients with non-COVID ARDS. Of 
145 patients with non-COVID ARDS, pneumonia was 
the leading cause of ARDS in 124 patients (85.5%). We 
compared patients by dividing them into three groups: 
COVID-19 ARDS, non-COVID ARDS due to pneu-
monia, and non-COVID ARDS not due to pneumonia 
(Additional file  1: Table  S3). Among the patients with 
non-COVID ARDS, oxygenation and Crs responses to 
prone positioning did not differ regardless of whether 
the underlying cause was pneumonia or not.
Fig. 1 Changes in  PaO2/FiO2 ratio and static respiratory system compliance after the first session of prone positioning. A  PaO2/FiO2 ratio; B Static 
respiratory system compliance
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Association between clinical outcomes
In patients with COVID-19 ARDS, successful discon-
tinuation of mechanical ventilation was achieved in 
16 of 23 patients (69.6%) within 90  days after the first 
session of prone positioning. We evaluated whether 
the changes in  PaO2/FiO2 ratio and static Crs after the 
first prone positioning session were associated with 
successful discontinuation of mechanical ventilation. 
Improvement in  PaO2/FiO2 ratio was more pronounced 
in patients who successfully discontinued mechani-
cal ventilation than in those who did not [median 112 
(IQR 85–144) vs. 35 (IQR 6–52) mmHg, P = 0.003]. 
In patients who successfully discontinued mechanical 
ventilation, static Crs increased by a median of 5.7 (IQR 
3.3–7.7) mL/cmH2O, whereas in patients who did not, 
it decreased by a median of 1.0 (IQR −  3.0–3.7) mL/
cmH2O (P = 0.006).
In ROC analysis, the areas under the curve were 
0.893 (0.754–1.000) for the change in  PaO2/FiO2 ratio 
and 0.866 (0.714–1.000) for the change in static Crs in 
predicting successful discontinuation of mechanical 
ventilation within 90  days (Fig.  2). In competing risk 
regression analysis, the extent of improvement in  PaO2/
FiO2 ratio (SHR 1.19, 95% CI 1.08–1.30 per 10 mmHg 
increase) and static Crs (SHR 1.57, 95% CI 1.29–1.91 
per 1  mL/cmH2O increase) after the first prone posi-
tioning session were both associated with successful 
discontinuation of mechanical ventilation (Table  4). 
Among other variables, female sex, lower SOFA score, 
and higher baseline static Crs were associated with 
higher probability of successful discontinuation of 
mechanical ventilation.
Literature review for related studies
Given the limited sample size of our study, we performed 
additional literature review for other related studies 
investigating the physiological effects of prone position-
ing in mechanically ventilated patients with COVID-19 
ARDS (Table 5). As of June 2021, we were able to iden-
tify 16 studies, and all studies retrieved showed that 
prone positioning substantially improves oxygenation in 
patients with COVID-19 ARDS. However, responses of 
static Crs varied between the studies.
Discussion
In this study, we compared the physiological response 
of prone positioning between patients with COVID-19 
ARDS and non-COVID ARDS, focusing on changes in 
oxygenation and static Crs. Most patients with COVID-
19 ARDS showed improvement in  PaO2/FiO2 ratio and 
static Crs after the first session of prone positioning. The 
extent of improvement in these parameters appeared to 
be higher in patients with COVID-19 ARDS when com-
pared crudely with the entire group of patients with non-
COVID ARDS. However, when 1:1 matched samples 
 (PaO2/FiO2-matched and compliance-matched) were 
analyzed, the physiological response to prone positioning 
Table 3 PaO2/FiO2 ratio and static respiratory system compliance responses after the first prone positioning session
CI confidence interval, FiO2 fraction of inspired oxygen, IQR interquartile range, PaO2 partial pressure of oxygen
a For multivariable linear regression, the following variables were adjusted: age, sex, body mass index, duration of mechanical ventilation before initiation of prone 
positioning, sequential organ failure assessment (SOFA) score, Charlson comorbidity index (CCI), baseline setting of mechanical ventilator (positive end-expiratory 
pressure and tidal volume), and baseline respiratory mechanics before initiation of prone positioning  (PaO2/FiO2, static compliance, and ventilatory ratio)
Entire group PaO2/FiO2‑matched Compliance‑matched
N = 168 P value N = 46 P value N = 46 P value
PaO2/FiO2 ratio
 Change at the end of the first prone positioning session, mmHg
  COVID‑19 ARDS, median (IQR) 89.8 (35.3–135.2) 0.003 89.8 (35.3–135.2) 0.091 89.8 (35.3–135.2) < 0.001
  Non‑COVID ARDS, median (IQR) 40.1 (7.0–77.5) 48.7 (5.0–87.0) 21.1 (0.0–43.8)
 Regression coefficient (COVID vs. non‑COVID)
  Unadjusted (95% CI) 46.7 (17.8–75.6) 0.002 32.5 (− 14.7–79.8) 0.172 69.7 (31.2–108.2) 0.001
  Adjusted (95% CI)a 39.3 (5.2–73.5) 0.024 4.0 (− 62.9–71.0) 0.903 58.4 (− 13.5–130.2) 0.108
Static respiratory system compliance
 Change at the end of the first prone positioning session, mL/cmH2O 
  COVID‑19 ARDS, median (IQR) 3.7 (− 1.0–7.3) < 0.001 3.7 (− 1.0–7.3) 0.044 3.7 (− 1.0–7.3) < 0.001
  Non‑COVID ARDS, median (IQR) − 0.3 (− 4.0–1.9) 0.4 (− 1.2–2.3) − 2.3 (− 7.2–0.0)
 Regression coefficient (COVID vs. non‑COVID)
  Unadjusted (95% CI) 4.2 (2.3–6.2) < 0.001 2.7 (0.0–5.5) 0.047 6.6 (3.8–9.3) < 0.001
  Adjusted (95% CI)a 3.4 (1.1–5.6) 0.003 0.3 (− 3.3–3.8) 0.883 2.2 (− 2.4–6.7) 0.340
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was not different between patients with COVID-19 
ARDS and those with non-COVID ARDS.
Whether patients with COVID-19 ARDS have a clini-
cally different phenotype compared with those with 
typical non-COVID ARDS continues to be a controver-
sial issue [5, 22]. One of the issues related to this con-
troversy is regarding static Crs. Since the COVID-19 
pandemic started, some patients with COVID-19 ARDS 
have been reported to have preserved static Crs despite 
impaired oxygenation, which is referred to as “type L 
(low elastance) phenotype” compared with “type H (high 
elastance) phenotype” [22, 23]. A multicenter study in 
Italy reported that patients with COVID-19 ARDS had 
higher median static Crs than those with non-COVID 
ARDS (41 vs. 32 mL/cmH2O), although there was a sub-
stantial overlap between the two groups [11]. However, 
in several other studies, patients with COVID-19 ARDS 
presented with static Crs of approximately 30–35  mL/
cmH2O, which is similar to that in previous reports of 
typical non-COVID ARDS [6, 10, 24–27].
Fig. 2 Receiver operating characteristic curve for changes in  PaO2/FiO2 ratio and static respiratory system compliance in predicting the successful 
discontinuation of mechanical ventilation. A  PaO2/FiO2 ratio; B Static respiratory system compliance
Table 4 Predictors of successful discontinuation of mechanical ventilation for patients with COVID‑19 ARDS
FiO2 fraction of inspired oxygen, PaO2 partial pressure of oxygen, SOFA sequential organ failure assessment
a Subdistribution hazard ratios are described with their 95% confidence intervals
Predictors (N = 23) Subdistribution hazard  ratioa P value
Age (per 1 year) 1.18 (0.99–1.40) 0.063
Female sex (vs. Male sex) 13.92 (1.17–165.15) 0.037
SOFA score (per 1 point) 0.68 (0.49–0.95) 0.022
Charlson comorbidity index (per 1 point) 0.48 (0.17–1.39) 0.176
Baseline  PaO2/FiO2 ratio (per 10 mmHg) 0.73 (0.53–1.00) 0.054
Baseline static respiratory system compliance (per 1 mL/cmH2O) 1.40 (1.10–1.79) 0.006
Increase in  PaO2/FiO2 ratio after the first prone positioning session (per 10 mmHg) 1.19 (1.08–1.30) < 0.001
Increase in static respiratory system compliance after the first prone positioning session (per 
1 mL/cmH2O)
1.57 (1.29–1.91) < 0.001
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In our study, patients in both groups showed sub-
stantially reduced static Crs (median 27.2 and 21.9 mL/
cmH2O in COVID-19 and non-COVID group, respec-
tively). Especially, patients with non-COVID ARDS in 
this study had extremely poor static Crs considering that 
a recent secondary analysis of the LUNG SAFE study, 
which included a large multinational cohort of patients, 
reported the median static Crs of 30  mL/cmH2O [28]. 
This may be due to the selection bias that occurs in 
single-center studies. In fact, we could not identify any 
patient in either group (COVID-19 or non-COVID) 
who can be classified as having type L phenotype (static 
Crs ≥ 50 mL/cmH2O). Therefore, our findings may not be 
applicable to patients with type L phenotype.
Almost every patient with COVID-19 ARDS in this 
study showed improvement in  PaO2/FiO2 ratio after 
prone positioning. Such improvement was rapid and 
most noticeable after 10  h of prone positioning. This 
Table 5 Literature review for studies evaluating efficacy of prone positioning in mechanically ventilated patients with COVID‑19 ARDS
CI confidence interval, FiO2 fraction of inspired oxygen, IQR interquartile range, N.A. not available, PaO2 partial pressure of oxygen, SD standard deviation
Study author Number 
of 
patients
Study region Timing of response 
evaluation
Change in  PaO2/FiO2 ratio 
(mmHg)
Change in compliance (mL/
cmH2O)
Present study by Jimyung 
Park
23 South Korea End of first proning session Median 107 (IQR 92–132) 
→ median 196 (IQR 
161–248)
Median 27.2 (IQR 21.9–32.7)
→ median 31.5 (IQR 
25.2–37.0)
Osama Abou‑Arab [41] 25 France End of first proning session Median 91 (95% CI 78–137)
→ median 124 (95% CI 
97–149)
Median 32 (95% CI 21–38)
→ median 32 (95% CI 23–40)
Alfredo J Astua [42] 29 U.S.A End of first proning session Mean 107.5 ± 5.6
→ mean 142.0 ± 10.8
N.A
Max Berrill [43] 34 U.K End of every proning session Mean 99.8 ± 100
→ mean 151.9 ± 58.9
N.A
Jennifer Clarke [44] 20 Ireland During first proning session Median 123 (IQR 100–154)
→ median 286 (IQR 
195–348)
Median 33.7 (IQR 30.1–43.0)
→ median 32.5 (IQR 
26.7–37.5)
Ivor S Douglas [45] 61 U.S.A 2 h after starting proning Median 99 (IQR 73–128)
→ median 136 (IQR 
105–164)
N.A
Helena Gleissman [46] 44 Sweden End of first proning session Median 104 (IQR 86–122)
→ median 161 (IQR 
127–207)
N.A
Rohit Khullar [47] 23 U.S.A End of last proning session Mean 84.8 (SD N.A.) 
→ mean 202.0 (SD N.A.)
N.A
Thomas Langer [48] 78 Italy End of first proning session Median 98 (IQR 72–121)
→ median 158 (IQR 
112–220)
Median 43 (IQR 31–50)
→ median 42 (IQR 35–48)
Mirja Mittermaier [49] 9 Germany 12 h after starting proning Mean 118.4 ± 41.9
→ mean 181.8 ± 63.2
N.A
François Perier [50] 9 France 3 h after starting proning N.A Median 44 (IQR 38–55)
→ median 39 (IQR 32–53)
Ling Sang [51] 20 China End of first proning session Mean 68.0 ± 10.3
→ mean 82.4 ± 15.5
Mean 17.5 ± 3.5
→ mean 20.6 ± 4.4
Gaetano Scaramuzzo [52] 191 Italy 3 h after resupination Median 49% improvement 
(IQR 19–100%)
N.A
Mehdi C Shelhamer [53] 62 U.S.A During first proning session Improvement by 36.4 mmHg 
(49% improvement)
N.A
Richard Vollenberg [54] 13 Germany 6 h after starting proning Median 58% improvement 
(IQR 31–95%)
Median 38 (IQR 26–58)
→ median 39 (IQR 27–59)
Tyler T Weiss [29] 36 U.S.A 2 h after starting proning Median 131 (IQR 87–144)
→ median 208 (IQR 
146–268)
Median 29.2 (IQR 23.3–35.5)
→ median 29.2 (IQR 
24.0–36.2)
David R Ziehr [55] 122 U.S.A End of first proning session Median 149 (IQR 123–170)
→ median 235 (IQR 
186–285)
Median 31 (IQR 27–39)
→ median 33 (IQR 28–38)
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finding is consistent with that of another single-center 
study of intubated patients with COVID-19 treated using 
prone positioning, which reported that  PaO2/FiO2 ratio 
improved within 2  h after initiation of prone position-
ing [29]. In a prospective study of prone positioning in 
nonintubated patients, improvement in oxygenation was 
observed even 10 min after initiation of prone position-
ing [30]. In contrast, a previous study on non-COVID 
ARDS showed that the oxygenation status was not always 
improved immediately after initiation of prone position-
ing [31]. In other studies, including the PROSEVA trial, 
 PaO2/FiO2 ratio was higher at the end of the prone posi-
tioning session than at 1 h after initiation of prone posi-
tioning, which is similar to our findings for patients with 
non-COVID ARDS [7, 32]. Based on these findings, it can 
be suggested that the speed of the oxygenation response 
after prone positioning may differ between patients with 
COVID-19 ARDS and those with non-COVID ARDS. 
Because  PaO2/FiO2 ratio cannot be monitored on real-
time basis, monitoring oxygenation based on  SpO2/FiO2 
ratio might provide more information on this issue.
The change in static Crs after prone positioning has 
not been studied as much as the change in oxygenation. 
In one study, static Crs was improved with prone posi-
tioning when it was accompanied only with application 
of high PEEP, but not with low PEEP [33]. Crs is deter-
mined by compliance of the chest wall and lung. Because 
chest wall compliance usually decreases during prone 
positioning, the overall change in Crs after prone posi-
tioning depends on how much the compliance of the lung 
improves, which may be related to lung recruitability 
[8]. In our study, the extent of improvement in static Crs 
after prone positioning appeared to be higher in patients 
with COVID-19 ARDS than in patients with non-COVID 
ARDS in a crude analysis. However, the difference was 
not significant when the analysis was performed using 
the matched samples. In addition to static Crs, it may 
be useful to monitor the lung recruitability while imple-
menting prone positioning [34–37].
The major finding of our study was that oxygenation 
and Crs responses after prone positioning were not 
different between patients with COVID-19 ARDS and 
those with non-COVID ARDS after careful matching 
and adjusting for baseline between-group differences. 
It is intriguing that the unmatched analysis suggested 
that prone positioning was more effective in patients 
with COVID-19 ARDS than in those with non-COVID 
ARDS. However, this finding may have resulted from 
the effects of unmeasured confounding factors, sug-
gesting that our 1:1 matched analysis is more appro-
priate for a proper comparison. Taking the findings 
of both unmatched and 1:1 matched analyses into 
account, the physiological effects of prone position-
ing in COVID-19 ARDS may be comparable with, or 
at least not inferior to, those in typical non-COVID 
ARDS.
In fact, because non-COVID ARDS comprises lung 
injuries from very heterogeneous causes, it is not easy 
to make a proper comparison between the two groups. 
Furthermore, although COVID-19 ARDS occurs by 
infection caused by a common single pathogen, results 
of several studies indicated that respiratory mechanics 
of patients with COVID-19 ARDS show a substantial 
interindividual variability, highlighting the importance 
of individualization in ventilator management [38]. As 
in our study, it may be because of this interindividual 
variability that other studies also failed to identify sig-
nificant differences between COVID-19 ARDS and 
non-COVID ARDS [39, 40].
We have recently reported that the extent of improve-
ment in oxygenation after the first session of prone 
positioning could be predictive of clinical outcome 
for patients with non-COVID ARDS [9]. In this study, 
we confirmed this finding in patients with COVID-19 
ARDS. In addition, we found that the improvement in 
static Crs after prone positioning was also associated 
with clinical outcome. Our findings suggest that if the 
physiological effect of prone positioning is not substan-
tial at the end of the first session, intensivists may have 
to consider other therapeutic options. By comparison, a 
post hoc analysis of the PROSEVA trial found no asso-
ciation between the improvement in oxygenation after 
1  h of prone positioning and survival outcomes [16]. 
This discrepancy may have arisen from the difference 
in the timing of evaluating the response to prone posi-
tioning. Given that it is not clear which timepoint after 
initiating prone positioning is most appropriate for 
response evaluation, more studies are needed to clarify 
this issue.
Our study has several limitations. First, our study was 
conducted at a single center and the number of patients 
studied was limited, although we enrolled every con-
secutive patient treated using prone positioning until 
December 2020. To compensate for this limitation, we 
performed additional literature review for other related 
studies. All studies retrieved consistently showed that 
prone positioning is effective in improving oxygenation 
in patients with COVID-19 ARDS. Second, despite our 
efforts to adjust for between-group differences includ-
ing 1:1 matched analysis, we cannot exclude the possi-
bility that uncontrolled individual factors affected our 
study findings. Third, we could not evaluate the effect 
of prone positioning in patients with preserved static 
Crs (type L phenotype), because there were no such 
patients in our cohort.
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Conclusions
In conclusion, in patients with COVID-19 ARDS, prone 
positioning was as effective in improving oxygenation 
and static Crs as in patients with non-COVID ARDS. 
Although interindividual variability in respiratory 
mechanics indicates the need for more individualized 
approaches in ventilator management, our study findings 
suggest that prone positioning should be actively con-
sidered for patients with moderate-to-severe COVID-19 
ARDS. In addition, the physiological response to the first 
session of prone positioning should be monitored to pre-
dict the future clinical outcome.
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